These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34040908)

  • 21. Transthyretin Cardiac Amyloidosis in an Elderly Male With Heart Failure Intolerant to Guideline-Directed Medical Therapy.
    Ene N; Ingram T; Bhandari M
    Cureus; 2024 Jun; 16(6):e62722. PubMed ID: 39036123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).
    Klaassen SHC; Lemmink HH; Bijzet J; Glaudemans AWJM; Bos R; Plattel W; van den Berg MP; Slart RHJA; Nienhuis HLA; van Veldhuisen DJ; Hazenberg BPC
    Cardiovasc Pathol; 2017; 29():19-22. PubMed ID: 28460244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
    Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
    Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coexisting transthyretin and atrial natriuretic peptide amyloid on left atrium in transthyretin amyloid cardiomyopathy.
    Kuyama N; Takashio S; Nakamura K; Nishigawa K; Hanatani S; Usuku H; Yamamoto E; Ueda M; Fukui T; Tsujita K
    J Cardiol Cases; 2024 Jun; 29(6):261-264. PubMed ID: 38826764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac amyloidosis: evolving approach to diagnosis and management.
    Meier-Ewert HK; Sanchorawala V; Berk JL; Ruberg FL
    Curr Treat Options Cardiovasc Med; 2011 Dec; 13(6):528-42. PubMed ID: 21989745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis.
    Perlini S; Mussinelli R; Salinaro F
    Curr Heart Fail Rep; 2016 Dec; 13(6):267-272. PubMed ID: 27900617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart of the Matter: Decoding the Underdiagnosed Cardiac Amyloidosis.
    Kaiser ME; Lewis TJ
    Cureus; 2023 Dec; 15(12):e50527. PubMed ID: 38098740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
    Sekijima Y
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent Heart Failure Despite Medical Therapy Leading to a Diagnosis of Cardiac Amyloidosis.
    Maraj D; Ramanan S; Patel PM; Memon M; Hawes E
    Cureus; 2023 Aug; 15(8):e43547. PubMed ID: 37719596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restrictive cardiomyopathy in inherited ATTR amyloidosis (TTR-Ser23Asn) in a patient of German-Italian extraction.
    Mueller II; Gawaz M; Linke RP; Zuern C; Steiner D; Altland K; Von Beckerath N; Weig HJ
    BMJ Case Rep; 2010; 2010():. PubMed ID: 22400056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac amyloidosis-an underdiagnosed cause of heart failure in the elderly.
    Nazir T; Nuffati M
    J Saudi Heart Assoc; 2020; 32(1):98-102. PubMed ID: 33154899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac amyloidosis: Recent advances in the diagnosis and therapy.
    Çavuşoğlu Y; Özpelit E; Çelik A; İkitimur B; Kayıkçıoğlu M; Tokgözoğlu L; Tüfekçioğlu O; Yılmaz MB
    Turk Kardiyol Dern Ars; 2019 Jun; 47(Suppl 2):1-34. PubMed ID: 31364995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical characterisation of amyloid by endomyocardial biopsy.
    Benson MD; Breall J; Cummings OW; Liepnieks JJ
    Amyloid; 2009 Mar; 16(1):9-14. PubMed ID: 19291509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
    Paton DM
    Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in the diagnosis and management of amyloid cardiomyopathy.
    Nijst P; Tang WW
    Fac Rev; 2021; 10():31. PubMed ID: 33817700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transthyretin cardiac amyloidosis: an update on diagnosis and treatment.
    Yamamoto H; Yokochi T
    ESC Heart Fail; 2019 Dec; 6(6):1128-1139. PubMed ID: 31553132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of amyloidosis: present and future.
    Mallus MT; Rizzello V
    Eur Heart J Suppl; 2023 Apr; 25(Suppl B):B99-B103. PubMed ID: 37091663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carpal Tunnel Syndrome in Transthyretin Cardiac Amyloidosis: Implications and Protocol for Diagnosis and Treatment.
    Boyle RP; Sharan J; Schwartz G
    Cureus; 2021 Apr; 13(4):e14546. PubMed ID: 34017661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
    Klaassen SH; van Veldhuisen DJ; Nienhuis H; van den Berg MP; Hazenberg BP; van der Meer P
    Card Fail Rev; 2020 Mar; 6():e21. PubMed ID: 32944291
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.